Neuroprotective effects of nicotinamide and 1-methylnicotinamide in acute excitotoxicity in vitro.

Nicotinamide (NAM), an important cofactor in many metabolic pathways, exhibits at high doses neuroprotective abilities of an unclear mechanism. In the present study we evaluated the unknown protective capability of its immediate metabolite 1-methylnicotinamide (MNA) in comparison to NAM in primary cultures of rat cerebellar granule cells (CGC) submitted to acute excitotoxicity. Neurotoxicity was evaluated with propidium iodide staining 24 h after 30 min exposure to glutamate (GLU) and NMDA. NAM and MNA reduced NMDA toxicity only at 25 mM concentration, while neurotoxicity of 0.5 mM GLU was slightly diminished only by 25 mM NAM. Both compounds at 25 mM reduced GLU-induced 45Ca uptake and dose-dependently inhibited NMDA-induced 45Ca accumulation. Neither NAM nor MNA interfered with GLU-evoked intracellular calcium transients evaluated with calcium orange fluorescent probe or inhibited [3H]MK-801 binding to rat cortical membranes. NAM and MNA failed to change GLU-evoked decrease in mitochondrial membrane potential monitored using the fluorescent dye rhodamine 123. Analysis with a hydroperoxide-sensitive fluorescent probe demonstrated significant reduction by 20 and 25 mM MNA, but not NAM, of oxidative stress in cultures after 1 h treatment with GLU. CGC accumulated radiolabelled NAM and MNA in a time and concentration dependent manner, NAM being transported more rapidly. These findings demonstrate that weak neuroprotective ability of MNA in excitotoxicity, accompanied by incomplete stabilization of calcium imbalance and lessening of oxidative stress, is not connected with direct inhibition of NMDA receptors. The exact mechanisms of these effects require further investigation.

[1]  E. Salińska,et al.  Dantrolene antagonizes the glycineB site of the NMDA receptor , 2008, Neuroscience Letters.

[2]  K. Bryniarski,et al.  Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. , 2008, European journal of pharmacology.

[3]  J. Lazarewicz,et al.  Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells. , 2008, Acta neurobiologiae experimentalis.

[4]  A. Adamczyk,et al.  GSK-3beta and oxidative stress in aged brain. Role of poly(ADP- -ribose) polymerase-1. , 2007, Folia neuropathologica.

[5]  W. Buczko,et al.  1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway , 2007, British journal of pharmacology.

[6]  N. Zoremba,et al.  Changes in diffusion parameters, energy-related metabolites and glutamate in the rat cortex after transient hypoxia/ischemia , 2006, Neuroscience Letters.

[7]  K. I. Maynard,et al.  Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats. , 2006, Current neurovascular research.

[8]  E. Matyja,et al.  Excitotoxic neuronal injury in acute homocysteine neurotoxicity: Role of calcium and mitochondrial alterations , 2006, Neurochemistry International.

[9]  M. Kajta,et al.  The mechanism of 1,2,3,4‐tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate‐induced excitotoxicity , 2006, Journal of neurochemistry.

[10]  I. Paul,et al.  Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat , 2006, Brain Research Bulletin.

[11]  D. Muller,et al.  Glutamate receptor changes associated with transient anoxia/hypoglycaemia in hippocampal slice cultures , 2006, The European journal of neuroscience.

[12]  J. Lazarewicz,et al.  Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. , 2006, Acta neurobiologiae experimentalis.

[13]  W. Danysz,et al.  The role of excitotoxicity in neurodegeneration. , 2006, Folia neuropathologica.

[14]  Adrian C. Williams,et al.  Nicotinamide: a double edged sword. , 2005, Parkinsonism & related disorders.

[15]  K. I. Maynard,et al.  Nicotinamide Modulates Energy Utilization and Improves Functional Recovery from Ischemia in the In Vitro Rabbit Retina , 2005, Annals of the New York Academy of Sciences.

[16]  A. Williams,et al.  Parkinson's disease: the first common neurological disease due to auto-intoxication? , 2005, QJM : monthly journal of the Association of Physicians.

[17]  Susan X. Jiang,et al.  Group B vitamins protect murine cerebellar granule cells from glutamate/NMDA toxicity , 2004, Neuroreport.

[18]  K. Maiese,et al.  Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. , 2004, Frontiers in bioscience : a journal and virtual library.

[19]  J. Simon,et al.  NAD to the Rescue , 2004, Science.

[20]  K. Maiese,et al.  The NAD+ Precursor Nicotinamide Governs Neuronal Survival During Oxidative Stress Through Protein Kinase B Coupled to FOXO3a and Mitochondrial Membrane Potential , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  K. Jeng,et al.  Protective Effect of Nicotinamide on Neuronal Cells under Oxygen and Glucose Deprivation and Hypoxia/Reoxygenation , 2004, Journal of Biomedical Science.

[22]  J. Simon,et al.  Neuroscience. NAD to the rescue. , 2004, Science.

[23]  E. Zieminska,et al.  Dantrolene inhibits NMDA-induced 45Ca uptake in cultured cerebellar granule neurons , 2003, Neurochemistry International.

[24]  E. Zieminska,et al.  Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones , 2003, Neurochemistry International.

[25]  K. Maiese,et al.  Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. , 2003, Trends in pharmacological sciences.

[26]  J. Adamus,et al.  1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. , 2003, Polish journal of pharmacology.

[27]  H. Koepsell,et al.  The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules , 2002, Journal of Pharmacology and Experimental Therapeutics.

[28]  K. Maiese,et al.  Nicotinamide Modulates Mitochondrial Membrane Potential and Cysteine Protease Activity during Cerebral Vascular Endothelial Cell Injury , 2002, Journal of Vascular Research.

[29]  R. Waring,et al.  Expression of Nicotinamide N‐Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian Brain , 2002, Journal of neuropathology and experimental neurology.

[30]  T. Fukushima,et al.  Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. , 2002, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[31]  P. Carlen,et al.  Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. , 2001, Free radical biology & medicine.

[32]  H. Fujita,et al.  Apoptosis Induced by Nicotinamide-related Compounds and Quinolinic Acid in HL-60 Cells , 2000, Bioscience, biotechnology, and biochemistry.

[33]  C. Ogilvy,et al.  After Transient Focal Cerebral Ischemia in Wistar Rats ) Improves Neurological Outcome and 3 Delayed Treatment With Nicotinamide ( Vitamin B , 2000 .

[34]  G. Hu,et al.  Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex , 1999, Neuroscience Letters.

[35]  F. Oesch,et al.  Formation of N-methylnicotinamide in the brain from a dihydropyridine-type prodrug: effect on brain choline. , 1999, Biochemical pharmacology.

[36]  F. Lang,et al.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.

[37]  K. Kaneda,et al.  Effects of B vitamins on glutamate-induced neurotoxicity in retinal cultures. , 1997, European journal of pharmacology.

[38]  K. Shiwaku,et al.  Radical formation site of cerebral complex I and Parkinson's disease , 1995, Journal of neuroscience research.

[39]  M. Goldberg,et al.  Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  S. Lipton,et al.  Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.

[41]  I. Reynolds,et al.  Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  J. Dykens Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration , 1994, Journal of neurochemistry.

[43]  K. Giacomini,et al.  Transport of organic cations by a renal epithelial cell line (OK). , 1991, The Journal of biological chemistry.

[44]  R. Moseley,et al.  Transport of N1-methylnicotinamide by organic cation-proton exchange in rat liver membrane vesicles. , 1990, The American journal of physiology.

[45]  V. Gallo,et al.  Glutamate Receptor Subtypes in Cultured Cerebellar Neurons: Modulation of Glutamate and γ‐Aminobutyric Acid Release , 1987, Journal of neurochemistry.

[46]  A. Guidotti,et al.  Endogenous ligands for benzodiazepine recognition sites. , 1985, Biochemical pharmacology.

[47]  D. Choi,et al.  Glutamate neurotoxicity in cortical cell culture is calcium dependent , 1985, Neuroscience Letters.

[48]  A. Schousboe,et al.  Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids. , 1985, Developmental neuroscience.

[49]  L. Pieri,et al.  Nicotinamide is a brain constituent with benzodiazepine-like actions , 1979, Nature.